ATARA BIOTHERAPEUTICS, INC. Increase (Decrease) in Inventories
ATARA BIOTHERAPEUTICS, INC. (ATRA) reported Increase (Decrease) in Inventories of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-08-12
- ATARA BIOTHERAPEUTICS, INC. increase (decrease) in inventories for the quarter ending 2026-06-30 was $0.00.
- ATARA BIOTHERAPEUTICS, INC. increase (decrease) in inventories for the quarter ending 2026-03-31 was $0.00.
- ATARA BIOTHERAPEUTICS, INC. increase (decrease) in inventories for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- ATARA BIOTHERAPEUTICS, INC. increase (decrease) in inventories for the quarter ending 2025-09-30 was $0.00.
- ATARA BIOTHERAPEUTICS, INC. increase (decrease) in inventories for fiscal 2025 was -$10.65M, a 340.30% decline from fiscal 2024.
- ATARA BIOTHERAPEUTICS, INC. increase (decrease) in inventories for fiscal 2024 was $4.43M, a 45.39% decline from fiscal 2023.
- ATARA BIOTHERAPEUTICS, INC. increase (decrease) in inventories for fiscal 2023 was $8.12M, a 411.98% increase from fiscal 2022.
- ATARA BIOTHERAPEUTICS, INC. increase (decrease) in inventories for fiscal 2022 was $1.59M.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $0.00 10-Q · filed 2026-08-12 | $0.00 derived: sum of 3 quarters · filed 2026-08-12 | $0.00 derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-12 | $0.00 derived: sum of 2 quarters · filed 2026-05-12 | $0.00 derived: sum of 3 quarters · filed 2026-05-12 | $0.00 derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $0.00 derived: sum of 2 quarters · filed 2026-03-16 | $0.00 derived: sum of 3 quarters · filed 2026-08-12 | -$10.65M 10-K · filed 2026-03-16 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2026-08-12 | -$10.65M 10-Q · filed 2025-11-12 | -$10.49M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$10.65M 10-Q · filed 2026-08-12 | -$10.49M derived: sum of 3 quarters · filed 2026-08-12 | -$15.26M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | -$10.65M 10-Q · filed 2026-05-12 | -$10.49M derived: sum of 2 quarters · filed 2026-05-12 | -$15.26M derived: sum of 3 quarters · filed 2026-05-12 | -$12.60M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $160.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$4.61M derived: sum of 2 quarters · filed 2026-03-16 | -$1.94M derived: sum of 3 quarters · filed 2026-03-16 | $4.43M 10-K · filed 2026-03-16 |
| 2024-09-30 | -$4.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$2.10M derived: sum of 2 quarters · filed 2025-11-12 | $4.27M 10-Q · filed 2025-11-12 | $7.39M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $2.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $9.04M 10-Q · filed 2025-08-11 | $12.16M derived: sum of 3 quarters · filed 2025-08-11 | $10.89M derived: sum of 4 quarters · filed 2025-08-11 |
| 2024-03-31 | $6.38M 10-Q · filed 2025-05-15 | $9.49M derived: sum of 2 quarters · filed 2025-05-15 | $8.22M derived: sum of 3 quarters · filed 2025-05-15 | $10.74M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $3.12M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $1.84M derived: sum of 2 quarters · filed 2025-03-07 | $4.37M derived: sum of 3 quarters · filed 2025-03-07 | $8.12M 10-K · filed 2025-03-07 |
| 2023-09-30 | -$1.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $1.25M derived: sum of 2 quarters · filed 2024-11-12 | $5.00M 10-Q · filed 2024-11-12 | $6.59M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $2.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $6.28M 10-Q · filed 2024-08-12 | $7.86M derived: sum of 3 quarters · filed 2024-08-12 | $7.86M derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $3.75M 10-Q · filed 2024-05-09 | $5.34M derived: sum of 2 quarters · filed 2024-05-09 | $5.34M derived: sum of 3 quarters · filed 2024-05-09 | $5.34M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $1.59M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $1.59M derived: sum of 2 quarters · filed 2024-03-28 | $1.59M derived: sum of 3 quarters · filed 2024-03-28 | $1.59M 10-K · filed 2024-03-28 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $0.00 derived: sum of 2 quarters · filed 2023-11-01 | $0.00 10-Q · filed 2023-11-01 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $0.00 10-Q · filed 2023-08-08 | ||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-08 | |||
| 2021-12-31 | $0.00 10-K · filed 2023-02-08 | |||
| 2020-12-31 | $0.00 10-K · filed 2023-02-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |